Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-26

FDA Approved: LOTEPREDNOL ETABONATE — Original Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved Sun Pharmaceutical Industries' Loteprednol etabonate as an Original Application (ANDA) for ophthalmic use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LOTEPREDNOL ETABONATE (Loteprednol etabonate)

Snippet

ORIG AP for LOTEPREDNOL ETABONATE (LOTEPREDNOL ETABONATE)